Antiplatelets and Vascular Dementia: A Systematic Review

Area of Science:

• Neurology
• Geriatrics
• Cardiovascular Medicine

Background:

• Vascular dementia (VD) is a neurocognitive disorder linked to cerebrovascular disease and impaired cerebral blood flow.
• It is a common cause of cognitive decline in the elderly, often associated with vascular risk factors like hypertension.
• Secondary stroke prevention is crucial, as repeated strokes increase cognitive decline and mortality risk.

Purpose of the Study:

• To systematically review the role of antiplatelet therapy in managing vascular dementia.
• To evaluate the current evidence supporting the use of antiplatelets in VD patients.
• To identify gaps in research regarding antiplatelet efficacy in VD.

Main Methods:

• Systematic review of published clinical trials and studies.
• Analysis of evidence on the use of antiplatelets (e.g., aspirin, clopidogrel) in VD management.
• Examination of data on secondary stroke prevention in VD patients.

Main Results:

• Antiplatelets are commonly prescribed for secondary stroke prevention in VD patients.
• Evidence directly supporting antiplatelet efficacy in ameliorating VD is limited and indirect.
• Risk management and prevention strategies have a strong rationale but require more direct data.

Conclusions:

• Antiplatelet therapy is a standard approach for secondary stroke prevention in vascular dementia.
• Further research is essential to establish the direct benefits and optimal use of antiplatelets in managing VD.
• More clinical trials are needed to provide robust evidence for antiplatelet treatment in VD.